John Joseph Johnston's most recent trade in MaxCyte Inc was a trade of 50,790 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MaxCyte Inc | John Joseph Johnston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 50,790 | 50,790 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 29,210 | 171,160 | - | 0 | Common Stock | |
| MaxCyte Inc | John Joseph Johnston | Director | 27 Jan 2025 | 3,000 | 144,950 | - | 2.9 | 8,796 | Common Stock | |
| MaxCyte Inc | John Joseph Johnston | Director | 27 Jan 2025 | 3,000 | 141,950 | - | 4.6 | 13,935 | Common Stock | |
| MaxCyte Inc | John Joseph Johnston | Director | 27 Jan 2025 | 3,000 | 17,417 | - | - | Stock Option (right to buy) | ||
| MaxCyte Inc | John Joseph Johnston | Independent Director | 27 Jan 2025 | 3,000 | 123,583 (0%) | 0% | 2.9 | 8,796 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Independent Director | 27 Jan 2025 | 1,300 | 120,883 (0%) | 0% | 4.7 | 6,071 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Independent Director | 27 Jan 2025 | 500 | 122,183 (0%) | 0% | 4.7 | 2,330 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Independent Director | 27 Jan 2025 | 300 | 122,883 (0%) | 0% | 4.6 | 1,380 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Independent Director | 27 Jan 2025 | 200 | 123,283 (0%) | 0% | 4.5 | 906 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Independent Director | 27 Jan 2025 | 200 | 122,683 (0%) | 0% | 4.6 | 928 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Independent Director | 27 Jan 2025 | 100 | 123,483 (0%) | 0% | 4.5 | 452 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Independent Director | 27 Jan 2025 | 100 | 123,183 (0%) | 0% | 4.6 | 456 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Independent Director | 27 Jan 2025 | 100 | 120,783 (0%) | 0% | 4.7 | 469 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Independent Director | 27 Jan 2025 | 100 | 120,683 (0%) | 0% | 4.7 | 470 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Independent Director | 27 Jan 2025 | 100 | 120,583 (0%) | 0% | 4.7 | 472 | Ords 0.01p | |
| MaxCyte Inc | John Johnston Joseph | Director | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 26 Dec 2024 | 3,000 | 141,950 | - | 4.0 | 12,021 | Common Stock |
| MaxCyte Inc | Joseph Johnston John | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 26 Dec 2024 | 3,000 | 144,950 | - | 2.9 | 8,796 | Common Stock |
| MaxCyte Inc | Johnston John Joseph | Non-Executive Director | 26 Dec 2024 | 3,000 | 123,583 (0%) | 0% | 2.9 | 8,796 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Dec 2024 | 3,000 | 20,417 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 26 Dec 2024 | 1,431 | 121,942 (0%) | 0% | 4 | 5,724 | Ords 0.01p |
| MaxCyte Inc | Johnston John Joseph | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 26 Dec 2024 | 300 | 121,392 (0%) | 0% | 4.0 | 1,203 | Ords 0.01p |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 26 Dec 2024 | 210 | 123,373 (0%) | 0% | 4.0 | 839 | Ords 0.01p |
| MaxCyte Inc | Joseph John Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.02 per share. | 26 Dec 2024 | 200 | 120,792 (0%) | 0% | 4.0 | 804 | Ords 0.01p |
| MaxCyte Inc | Joseph Johnston John | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 26 Dec 2024 | 200 | 121,192 (0%) | 0% | 4.0 | 802 | Ords 0.01p |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.02 per share. | 26 Dec 2024 | 200 | 120,992 (0%) | 0% | 4.0 | 803 | Ords 0.01p |
| MaxCyte Inc | Joseph John Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 26 Dec 2024 | 200 | 121,742 (0%) | 0% | 4 | 800 | Ords 0.01p |
| MaxCyte Inc | Joseph Johnston John | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 26 Dec 2024 | 153 | 120,639 (0%) | 0% | 4.0 | 617 | Ords 0.01p |
| MaxCyte Inc | John Johnston Joseph | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.05 per share. | 26 Dec 2024 | 56 | 120,583 (0%) | 0% | 4.1 | 227 | Ords 0.01p |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 26 Dec 2024 | 50 | 121,692 (0%) | 0% | 4 | 200 | Ords 0.01p |
| MaxCyte Inc | John Joseph Johnston | Director | Sale of securities on an exchange or to another person at price $ 3.79 per share. | 06 Dec 2024 | 2,495 | 141,950 | - | 3.8 | 9,459 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,121 | 0 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 06 Dec 2024 | 1,121 | 143,962 | - | 1.6 | 1,840 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 891 | 0 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 06 Dec 2024 | 891 | 142,841 | - | 2.9 | 2,607 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 06 Dec 2024 | 505 | 142,455 | - | 2.9 | 1,478 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 505 | 891 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Director | Sale of securities on an exchange or to another person at price $ 3.70 per share. | 06 Dec 2024 | 505 | 141,950 | - | 3.7 | 1,869 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 483 | 23,417 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 06 Dec 2024 | 483 | 144,445 | - | 2.9 | 1,416 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2024 | 3,000 | 1,396 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Director | Sale of securities on an exchange or to another person at price $ 3.72 per share. | 28 Oct 2024 | 3,000 | 141,950 | - | 3.7 | 11,166 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 28 Oct 2024 | 3,000 | 144,950 | - | 2.9 | 8,778 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 3.72 per share. | 28 Oct 2024 | 3,000 | 120,583 (0%) | 0% | 3.7 | 11,167 | Ords 0.01p |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | 28 Oct 2024 | 3,000 | 123,583 (0%) | 0% | 0 | Ords 0.01p | ||
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 26 Sep 2024 | 3,000 | 144,950 | - | 2.9 | 8,778 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | 26 Sep 2024 | 3,000 | 120,583 (0%) | 0% | 3.8 | 11,460 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | 26 Sep 2024 | 3,000 | 123,583 (0%) | 0% | 2.9 | 8,778 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2024 | 3,000 | 4,396 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Director | Sale of securities on an exchange or to another person at price $ 3.82 per share. | 26 Sep 2024 | 3,000 | 141,950 | - | 3.8 | 11,460 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 26 Aug 2024 | 3,000 | 144,950 | - | 2.9 | 8,778 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | 26 Aug 2024 | 3,000 | 120,583 (0%) | 0% | 0 | Ords 0.01p | ||
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | 26 Aug 2024 | 3,000 | 123,583 (0%) | 0% | 2.9 | 8,778 | Ords 0.01p | |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2024 | 3,000 | 7,396 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Director | Sale of securities on an exchange or to another person at price $ 4.28 per share. | 26 Aug 2024 | 3,000 | 141,950 | - | 4.3 | 12,840 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 26 Jul 2024 | 3,000 | 144,950 | - | 2.9 | 8,778 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.75 per share. | 26 Jul 2024 | 3,000 | 120,583 (0%) | 0% | 4.7 | 14,239 | Ords |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | 26 Jul 2024 | 3,000 | 123,583 (0%) | 0% | 2.9 | 8,778 | Ords | |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jul 2024 | 3,000 | 10,396 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Director | Sale of securities on an exchange or to another person at price $ 4.75 per share. | 26 Jul 2024 | 3,000 | 141,950 | - | 4.7 | 14,238 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Sale of securities on an exchange or to another person at price $ 3.99 per share. | 27 Jun 2024 | 10,000 | 141,950 | - | 4.0 | 39,900 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 27 Jun 2024 | 5,044 | 146,994 | - | 1.6 | 8,277 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2024 | 5,044 | 1,121 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 27 Jun 2024 | 4,956 | 151,950 | - | 2.9 | 14,501 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2024 | 4,956 | 13,396 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 40,701 | 40,701 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 21,367 | 141,950 | - | 0 | Common Stock | |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2024 | 5,000 | 617 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Director | Sale of securities on an exchange or to another person at price $ 4.40 per share. | 26 Mar 2024 | 5,000 | 120,583 | - | 4.4 | 22,025 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 26 Mar 2024 | 5,000 | 125,583 | - | 2.1 | 10,710 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 26 Feb 2024 | 5,000 | 125,583 | - | 2.1 | 10,710 | Common Stock |
| MaxCyte Inc | Johnston John Joseph | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 5,000 | 5,617 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Johnston Joseph | Director | Sale of securities on an exchange or to another person at price $ 4.60 per share. | 26 Feb 2024 | 5,000 | 120,583 | - | 4.6 | 23,005 | Common Stock |
| MaxCyte Inc | Joseph John Johnston | Non-Executive Director | 26 Feb 2024 | 5,000 | 125,583 (0%) | 0% | 2.1 | 10,710 | Ords | |
| MaxCyte Inc | John Johnston Joseph | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.60 per share. | 26 Feb 2024 | 901 | 122,712 (0%) | 0% | 4.6 | 4,145 | Ords |
| MaxCyte Inc | Joseph John Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.59 per share. | 26 Feb 2024 | 896 | 124,143 (0%) | 0% | 4.6 | 4,113 | Ords |
| MaxCyte Inc | Joseph Johnston John | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.63 per share. | 26 Feb 2024 | 737 | 120,583 (0%) | 0% | 4.6 | 3,409 | Ords |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.61 per share. | 26 Feb 2024 | 620 | 121,912 (0%) | 0% | 4.6 | 2,858 | Ords |
| MaxCyte Inc | Johnston Joseph John | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.60 per share. | 26 Feb 2024 | 467 | 123,613 (0%) | 0% | 4.6 | 2,146 | Ords |
| MaxCyte Inc | Johnston Joseph John | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.57 per share. | 26 Feb 2024 | 432 | 125,051 (0%) | 0% | 4.6 | 1,974 | Ords |
| MaxCyte Inc | Joseph Johnston John | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.62 per share. | 26 Feb 2024 | 366 | 121,320 (0%) | 0% | 4.6 | 1,691 | Ords |
| MaxCyte Inc | John Johnston Joseph | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.62 per share. | 26 Feb 2024 | 226 | 121,686 (0%) | 0% | 4.6 | 1,043 | Ords |
| MaxCyte Inc | Joseph John Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.61 per share. | 26 Feb 2024 | 180 | 122,532 (0%) | 0% | 4.6 | 829 | Ords |
| MaxCyte Inc | Joseph John Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 26 Feb 2024 | 100 | 125,483 (0%) | 0% | 4.5 | 451 | Ords |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.59 per share. | 26 Feb 2024 | 63 | 124,080 (0%) | 0% | 4.6 | 289 | Ords |
| MaxCyte Inc | Joseph Johnston John | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.58 per share. | 26 Feb 2024 | 12 | 125,039 (0%) | 0% | 4.6 | 55 | Ords |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 5.12 per share. | 26 Jan 2024 | 5,000 | 120,583 (0%) | 0% | 5.1 | 25,583 | Ords 0.01p |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 26 Jan 2024 | 5,000 | 125,583 | - | 2.1 | 10,710 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Sale of securities on an exchange or to another person at price $ 5.12 per share. | 26 Jan 2024 | 5,000 | 120,583 | - | 5.1 | 25,585 | Common Stock |
| MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2024 | 5,000 | 10,617 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | John Joseph Johnston | Non-Executive Director | 26 Jan 2024 | 5,000 | 125,583 (0%) | 0% | 2.1 | 10,710 | Ords 0.01p |